A Comparative Study of Incision Closure Methods for Total Knee Replacement
1 other identifier
interventional
75
1 country
1
Brief Summary
The aim of the study is to compare incision closure techniques for total knee replacement using a combination of state-of-the-art sutures with tissue adhesives or staples in an effort to identify the best approach with respect to time efficiency, cost, durability, dehiscence, microbial resistance and cosmesis. The hypothesis is that the combined suture/adhesive approach (sutures for capsule and subcutaneous layers, and tissue adhesive for the final cutaneous layer) or suture/staple approach will be significantly faster and of comparable durability as the conventional exclusive suture approach (sutures used for the capsule, subcutaneous, and cutaneous layers). This is a prospective, randomized, controlled, single site, unblinded (open label) study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 16, 2010
CompletedFirst Posted
Study publicly available on registry
March 17, 2010
CompletedAugust 22, 2012
August 1, 2012
7 months
March 16, 2010
August 21, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Outcome Measure
The primary endpoint is the mean procedure time improvement for TKA incision closure using a combined suture/adhesive or suture/staple approach versus suture closure alone.
1/2009-10/2009
Secondary Outcomes (1)
Mean postop hospital stay
1/2009-10/2009
Study Arms (4)
Histoacryl Tissue Adhesive
ACTIVE COMPARATORHistoacryl Blue (HAB) Tissue Adhesive (n-butyl-2 cyanoacrylate; B. Braun Corp., Melsungen, Germany). Histocryl is a FDA-approved sterile liquid skin adhesive that has been utilized as a substitute for sutures for wound closure for approximately 40 years.
Dermabond
ACTIVE COMPARATORDermabond High Viscosity Tissue Adhesive (2-ocytl cyanoacrylate; Ethicon, Somerville, NJ). Dermabond is also a FDA-approved liquid bonding agent that has been utilized for wound closure for approximately 10 years and proven as effective as sutures.
Staples
ACTIVE COMPARATORVisistat 35W Stapler (Teleflex Corp, Limerick, PA). The FDA-approved Weck staple system with stainless steel staples has been proven over years of use and remains the standard accepted closure approach due to speed of insertion as well as removal.
Running Subcuticular with Monocryl
ACTIVE COMPARATORMonocryl 4-0 Suture (Ethicon, Somerville, NJ). Monocryl is an FDA-approved absorbable, synthetic, suture indicated for soft tissue approximation.
Interventions
Eligibility Criteria
You may qualify if:
- TKA scheduled without a bilateral planned within one week of the initial surgery
- Willingness to attend prescribed physical therapy 3 times per week.
You may not qualify if:
- Current participation in another clinical trial
- Preoperative systemic infections
- Uncontrolled diabetes, or diseases or conditions known to effect the wound healing process
- Known hypersensitivity to cyanoacrylate
- Formaldehyde, or the dye D\&C Violet #2
- Prior knee hardware fixation devices
- Prior knee incisions greater than 9cm, and arthrofibrosis as evidence by limited ROM less than 80°.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foundation for Southwest Orthopedic Research
Houston, Texas, 77030, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2010
First Posted
March 17, 2010
Study Start
January 1, 2009
Primary Completion
August 1, 2009
Study Completion
October 1, 2009
Last Updated
August 22, 2012
Record last verified: 2012-08